Group One Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Group One Trading’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,000	Closed	-$950	–	8673
2023 Q2	$950	Sell	5,000 -3,200	-39%	-$1.26K	﹤0.01%	7267
2023 Q1	$2.79K	Hold	8,200	–	–	﹤0.01%	6518
2022 Q4	$2.44K	Sell	8,200 -2,000	-20%	-$724	﹤0.01%	6594
2022 Q3	$4K	Hold	10,200	–	–	﹤0.01%	6983
2022 Q2	$4K	Buy	10,200 +2,900	+40%	+$2.67K	﹤0.01%	7251
2022 Q1	$9K	Hold	7,300	–	–	﹤0.01%	7223
2021 Q4	$9K	Sell	7,300 -5,400	-43%	-$8.62K	﹤0.01%	7429
2021 Q3	$26K	Buy	12,700 +7,700	+154%	+$13.6K	﹤0.01%	7026
2021 Q2	$8K	Buy	+5,000	New	+$9.27K	﹤0.01%	7625
2021 Q1	–	Sell	-1,500	Closed	-$4K	–	8181
2020 Q4	$4K	Sell	1,500 -1,000	-40%	-$2.21K	﹤0.01%	6130
2020 Q3	$6K	Buy	2,500 +2,000	+400%	+$5.82K	﹤0.01%	5603
2020 Q2	$2K	Sell	500 -2,000	-80%	-$6.33K	﹤0.01%	5595
2020 Q1	$6K	Hold	2,500	–	–	﹤0.01%	4752
2019 Q4	$6K	Buy	+2,500	New	+$4.93K	﹤0.01%	4730
2019 Q1	–	Sell	-58,400	Closed	-$77K	–	5527
2018 Q4	$77K	Sell	58,400 -8,000	-12%	-$14.6K	﹤0.01%	3328
2018 Q3	$163K	Sell	66,400 -3,200	-5%	-$9.45K	﹤0.01%	3163
2018 Q2	$234K	Sell	69,600 -39,900	-36%	-$153K	﹤0.01%	2928
2018 Q1	$463K	Buy	109,500 +45,800	+72%	+$159K	﹤0.01%	2124
2017 Q4	$210K	Sell	63,700 -167,600	-72%	-$611K	﹤0.01%	2893
2017 Q3	$884K	Sell	231,300 -19,600	-8%	-$74.3K	0.01%	1644
2017 Q2	$1.1M	Sell	250,900 -107,500	-30%	-$441K	0.01%	1375
2017 Q1	$1.3M	Buy	358,400 +224,000	+167%	+$737K	0.02%	1147
2016 Q4	$359K	Buy	134,400 +31,600	+31%	+$98K	﹤0.01%	2004
2016 Q3	$335K	Buy	+102,800	New	+$336K	﹤0.01%	2108
2016 Q1	–	Sell	-22,000	Closed	-$72K	–	5073
2015 Q4	$72K	Buy	22,000 +11,800	+116%	+$39.6K	﹤0.01%	3201
2015 Q3	$35K	Buy	10,200 +8,200	+410%	+$19.1K	﹤0.01%	3749
2015 Q2	$3K	Buy	+2,000	New	+$2.79K	﹤0.01%	4626
2015 Q1	–	Sell	-6,000	Closed	-$2K	–	5314
2014 Q4	$2K	Buy	6,000 +700	+13%	+$1.49K	﹤0.01%	4712
2014 Q3	$23K	Buy	5,300 +2,000	+61%	+$9.8K	﹤0.01%	4043
2014 Q2	$16K	Sell	3,300 -4,800	-59%	-$24.7K	﹤0.01%	4298
2014 Q1	$44K	Buy	8,100 +2,800	+53%	+$16.2K	﹤0.01%	3723
2013 Q4	$32K	Sell	5,300 -2,000	-27%	-$13.6K	﹤0.01%	3975
2013 Q3	$48K	Sell	7,300 -3,600	-33%	-$23.5K	﹤0.01%	3576
2013 Q2	$56K	Buy	+10,900	New	+$55.2K	﹤0.01%	3339

Other funds holding NYMX

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

ODIJL

One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Group One Trading's NYMX Position: Q3 2023 in Review

Group One Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 5,307 shares — an estimated $1.01K sold.

Group One Trading first reported a position in NYMX in Q2 2013 and held it in 34 quarters. The position peaked at $295K in Q4 2017. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

Group One Trading reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
Group One Trading sold 5,307 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $1.01K.
Group One Trading first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 34 quarters.
Group One Trading's Nymox Pharmaceutical Corp position peaked at $295K in Q4 2017.
5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.